Skip to main content

Market Overview

Varian Medical Receives FDA 510(k) Clearance for ProBeam Proton Therapy System


Varian Medical Systems (NYSE: VAR) has received FDA 510(k) clearance for its updated ProBeam proton therapy system.

High resolution images are available in the Varian newsroom at the following URL:


Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software

See full press release


Related Articles (VAR)

View Comments and Join the Discussion!

Posted-In: News Guidance Financing Offerings Contracts FDA Management Global

Need corporate guidance data?
Click here to see licensing options.
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at